Healthcare Realty Trust Incorporated is a self-managed real estate investment trust that owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties primarily associated with the delivery of outpatient healthcare services throughout the United States. The company’s portfolio consists mainly of medical office and outpatient facilities, with a smaller presence in inpatient and office properties, often located on or near the campuses of acute care hospitals affiliated with major health systems. Its tenants include diverse physician groups and specialty centers such as surgery, imaging, cancer treatment, and diagnostic facilities. The company provides leasing and property management services for the majority of its portfolio and engages in development and redevelopment activities to support its growth strategy. Healthcare Realty Trust Incorporated positions itself as the first REIT to specialize in medical outpatient buildings.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry REIT - Healthcare Facilities Homepage healthcarerealty.com
Sector Real Estate IR page investors.healthcarerealty.com/corporate-profile/default.aspx
Tags
outpatient medical facilities, medical office buildings, healthcare real estate, property management, real estate development, surgery centers, imaging centers, cancer treatment centers, diagnostic centers, hospital-adjacent properties, Healthcare Realty Holdings L.P., Overlake Medical Pavilion, Baylor All Saints Pavilion I
Press page investors.healthcarerealty.com/corporate-profile/press-releases/default.aspx

Metrics

Valuation  
Market cap $ 6.032B
Market cap (USD) $ 6.032B
P/E -134.23
PEG —
P/BV 1.48
P/S 190.83
P/OCF 13.41
P/FCF 47.51
Dividend yield 6.2%
Turnover / mcap —
Returns  
ROE -5.0%
ROI -2.8%
ROIC 0.82%
Profit margin -872.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 104.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 21
Quality score 10.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007
Revenue 28.215M 19.157M 17.451M 13.706M 767.073M 738.965M 692.04M 696.426M 613.99M 460.928M 403.822M 371.505M 319.899M 299.644M 274.438M 203.081M 129.486M — —
Net profit -246.071M -654.485M -278.261M 40.897M 98.016M 52.618M 30.154M 213.463M 63.916M 45.912M 32.931M 45.371M 24.261M -24.424M 5.541M -7.903M -25.077M — —
Free cash flow 126.942M 252.636M 268.794M 109.203M 288.461M 313.219M 248.85M 259.526M 242.71M 160.701M 161.825M 139.462M 122.442M 93.876M 95.773M 43.615M 11.941M — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007
Share price 16.95 16.95 17.23 19.27 33.39 27.54 30.28 25.31 30.04 29.11 26.97 26.94 — — — — 16.25 16.25 23.25
Price performance 12m 0 -0.02 -0.11 -0.42 0.21 -0.09 0.2 -0.16 0.03 0.08 0 — — — — — 0 -0.3 -0.31

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Lease liabilities (USD) — — 0.00 199M 198M 196M 280M 230M 224M 163M
Cash and deposits (USD) 11.2M 100M 126M 32.7M 115M 52.4M 61M 25.7M 68.9M 26.2M
Intangible assets (USD) 278M 459M 373M 278M 239M 212M — — — —
Right-of-use assets (USD) — — 0.00 240M 235M 229M 337M 276M 261M 205M
Cash flow detail
Operating cash flow (USD) 204M 308M 337M 340M 388M 386M 273M 500M 502M 457M
Purchases of property, plant and equipment (USD) -43M -64.8M -77.9M -91.5M -74.7M -97.2M — — — —
Change in payables (cash effect) (USD) 2.17M 37.4M 9.48M -128,000 2.07M 9.43M 24.2M -18.8M 5.2M -25.5M
Dividends paid (cash effect) (USD) -159M -207M -253M -256M -276M -282M -284M -472M -458M -387M
Share buybacks (cash effect) (USD) -2.64M -3.41M -70.3M -12.2M -5.19M -3.41M -3.19M -2.3M -8.88M -4.01M
Interest paid (cash effect) (USD) -50.9M -65M -101M -94.7M -83.4M -80.4M -113M -216M -203M -177M
Income taxes paid (cash effect) (USD) -1.06M -1.33M -1.65M -2.13M -557,000 -560,000 -1.83M -1.32M -1.79M -1.26M
Share-based compensation (USD) 7.07M 6.87M 9.76M 10.1M 8.92M 7.26M 20.3M 14.3M 31.8M 22.4M
Free cash flow (OCF - PPE - intangibles) (USD) 161M 243M 260M 249M 313M 288M — — — —
Income detail
Total comprehensive income (USD) 47.3M 65.9M 218M 35.1M 31.6M 110M 52.9M -295M -654M -254M
Comprehensive income to owners (USD) 46M 64.3M 214M 34.5M 31.1M 108M 53M -291M -645M -250M
Provision for credit losses (USD) 846,000 400,000 — — 244M 0.00 0.00 — — —
Reported Feb 20, 2018 Feb 20, 2018 Apr 26, 2019 Feb 18, 2020 Mar 1, 2023 Mar 1, 2023 Mar 1, 2023 Feb 16, 2024 Feb 19, 2025 Feb 13, 2026

Operating KPIs — quarters

KPI Jun 22 Mar 23 Dec 23 Mar 24 Jun 24 Sep 24 Dec 24 Mar 25
Properties 276 657 657 657 585 585 585 585
↳ YoY growth +16.9% +149.8% 0% -11.0% -11.0%
Occupancy (%) — 89.0% 89.1% 89.3% 87.9% 88.1% 88.5% 89.0%
Reported Aug 9, 2022 May 7, 2024 May 7, 2024 May 7, 2024 May 1, 2025 May 1, 2025 May 1, 2025 May 1, 2025

Operating KPIs — years

KPI Dec 2021 Dec 2023 Dec 2024
Properties 258 657 585
↳ YoY growth -11.0%
Occupancy (%) — 89.1% 88.5%
Reported Aug 9, 2022 May 7, 2024 May 1, 2025

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Company Release - 10/29/2026

NASHVILLE, Tenn., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the third quarter ended September 30, 2026. In addition, the Company announced an increased 2026 Normalized FFO guidance range of $1.65 to $1.67 per share (diluted), a $0.02 increase at the midpoint from July guidance, and an increased Same Store Cash NOI growth guidance range of 5.00% to 5.25% (+75bps increase at the low end and +25bps at the high end from July guidance).

THIRD QUARTER 2026 HIGHLIGHTS

  • GAAP Net loss of $(0.05) per share, NAREIT FFO of $0.38 per share, Normalized FFO of $0.42 per share, and FAD of $110 million (payout ratio of 76%)
  • Same store cash NOI growth of 5.1%, tenant retention of 88.0% and cash leasing spreads averaging 8.6%  
  • Third quarter lease executions totaled 1.5 million square feet, including 430,000 square feet of new lease executions
  • Since last quarter, the Company acquired $211 million of assets (approximately $42 million at share) in its strategic joint venture with KKR
  • Since last quarter, the Company sold $68 million of assets, bringing year-to-date disposition activity to $136 million ($187 million including loan receivable repayments)
  • Net Debt to Adjusted EBITDA of 5.5x  
  • Repurchased 4.2 million shares of common stock through early October at an average share price of $17.74

THIRD QUARTER 2026 RESULTS

THIRD QUARTER ENDED
2026 2025
(in thousands, except per share amounts) AMOUNT PER SHARE AMOUNT PER SHARE
GAAP Net loss $ (15,755 ) $ (0.05 ) $ (57,738 ) $ (0.17 )
NAREIT FFO, diluted $ 131,666 $ 0.38 $ 118,922 $ 0.34
Normalized FFO, diluted $ 145,928 $ 0.42 $ 145,340 $ 0.41

LEASING ACTIVITY

During the third quarter, the Company executed 329 new and renewal leases for 1.5 million square feet with a weighted average lease term of 5.9 years and average annual escalators of 3.1%. Key highlights include:

  • Ascension Health. 203,000 square feet of new and renewal leases in Nashville across five on campus properties
  • Cedars Sinai Medical Center. 59,000 square feet of renewal leases in Los Angeles at a 95% occupied building
  • Mount Carmel Health System. 59,000 square feet of renewal leases across four properties in Columbus, OH
  • Indiana University Health. 38,000 square feet of renewal leases in Indianapolis, maintaining occupancy of more than 97% across two properties

CAPITAL ALLOCATION

Acquisition Activity

Since last quarter, the Company acquired $211 million of assets (approximately $42 million at share) in its strategic joint venture with KKR. Selected transactions include:

  • Charleston, SC. Acquired two health system anchored, Class A MOBs for $56 million ($11 million investment at share). The Company now owns 10 properties totaling 436,000 square feet in the market
  • Seattle, WA.   Acquired a 33,000 square foot health system anchored MOB for $17 million ($3 million investment at share), further strengthening the Company's footprint in the Seattle market

Disposition Activity

Since last quarter, the Company has disposed of $68 million of assets, bringing year-to-date disposition activity to $136 million. Selected transactions include:

  • Atlanta, GA. The Company completed a previously announced $36 million direct sale of a 59,000 square foot MOB to the affiliated hospital
  • Chicago, IL. During the quarter, the Company sold two properties for aggregate proceeds of $23 million and entered into a contract to sell the remaining property in the Chicago MSA. Upon completion of the sale, the Company will have fully exited the Chicago market

Development and Redevelopment

During the third quarter, the Company leased approximately 112,000 square feet and invested approximately $25 million across its redevelopment portfolio. Also during the quarter, the Company completed the redevelopment of a 40,400 square foot MOB in Raleigh, NC and commenced the redevelopment of a 60,500 square foot MOB in Austin, TX.

Balance Sheet

As of September 30, 2026, the Company had approximately $1.6 billion of liquidity across the revolving facility (net of commercial paper issuance), delayed draw term loan, and cash on hand.

In the third quarter and early October, the Company repurchased 4.2 million shares of common stock at an average price of $17.74 per share for a total of $75 million.

On October 26, 2026, the Company renewed its share repurchase program for the next 12 months with total authorization up to $500 million, replacing the expiring authorization from October 2025.

DIVIDEND

The Board unanimously approved a common stock dividend in the amount of $0.24 per share to be paid on November 20, 2026, to Class A common stockholders of record on November 10, 2026. Additionally, the eligible holders of operating partnership units will receive a distribution of $0.24 per unit, equivalent to the Company's Class A common stock dividend.

GUIDANCE

The Company further increased full year 2026 guidance ranges as follows:

2026 GUIDANCE
ACTUAL PRIOR (JULY) CURRENT
Q3 2026 LOW HIGH LOW HIGH
Earnings per share $ (0.05 ) $ (0.15 ) $ (0.11 ) $ (0.15 ) $ (0.11 )
NAREIT FFO per share $ 0.38 $ 1.45 $ 1.51 $ 1.48 $ 1.52
Normalized FFO per share $ 0.42 $ 1.62 $ 1.66 $ 1.65 $ 1.67
Same Store Cash NOI growth 5.1 % 4.25 % 5.00 % 5.00 % 5.25 %

The 2026 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any. The Company's guidance also does not include any future acquisitions, developments or share issuances or repurchases, other than as discussed in the detailed guidance assumptions on Page 10 of the Q3 2026 Supplemental. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results or timing vary from these assumptions, the Company's expectations may change. See Page 10 of the Q3 2026 Supplemental for additional details and assumptions.

EARNINGS CALL

On Friday, October 30, 2026, at 9:00 a.m. Eastern Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.

Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address.

Live Conference Call Access Details:

  • Domestic Dial-In Number: +1 833-461-5787
  • All Other Locations: +1 585-542-9983
  • Conference ID Number: 162 480 934

ABOUT HEALTHCARE REALTY

Healthcare Realty Trust Incorporated (NYSE: HR) is the largest public, pure-play owner, operator and developer of medical outpatient buildings in the United States.

For additional information contact [email protected].

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “target,” “intend,” “plan,” “estimate,” “project,” “continue,” “should,” “could," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: the Company’s expected results may not be achieved; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; pandemics or other health crises; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption “Risk Factors” and elsewhere in the Company’s filings and reports with the SEC, including the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company’s filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing. For a detailed discussion of the Company’s risk factors, please refer to the Company's filings with the SEC, including this report and the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.

Balance Sheet
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
ASSETS
Q3 2026 Q4 2025
Real estate properties
Land $ 1,040,660 $ 1,060,254
Buildings and improvements 8,673,665 8,514,165
Lease intangibles 378,664 455,254
Personal property 7,624 7,056
Investment in financing receivables, net 6,017 123,249
Financing lease right-of-use assets 73,894 75,083
Land held for development 35,564 57,535
Total real estate investments 10,216,088 10,292,596
Less accumulated depreciation and amortization (2,602,921 ) (2,397,795 )
Total real estate investments, net 7,613,167 7,894,801
Cash and cash equivalents 17,499 26,172
Assets held for sale, net 150,085 143,580
Operating lease right-of-use assets 202,383 204,906
Investments in unconsolidated joint ventures 481,521 453,607
Other assets, net 495,108 487,795
Total assets $ 8,959,763 $ 9,210,861
LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, AND STOCKHOLDERS' EQUITY
Liabilities
Notes and bonds payable $ 4,249,159 $ 3,911,423
Accounts payable and accrued liabilities 176,630 211,071
Liabilities of properties held for sale 13,510 15,160
Operating lease liabilities 163,793 162,922
Financing lease liabilities 74,475 73,130
Other liabilities 147,567 160,530
Total liabilities 4,825,134 4,534,236
Redeemable non-controlling interests 3,748 3,252
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized — —
Common stock, $0.01 par value; 1,000,000 shares authorized 3,400 3,516
Additional paid-in capital 8,895,212 9,137,257
Accumulated other comprehensive income (loss) 8,316 (5,174 )
Cumulative net income attributable to common stockholders 68,913 128,238
Cumulative dividends (4,895,426 ) (4,646,944 )
Total stockholders' equity 4,080,415 4,616,893
Non-controlling interest 50,466 56,480
Total equity 4,130,881 4,673,373
Total liabilities, redeemable non-controlling interests, and stockholders' equity $ 8,959,763 $ 9,210,861
Income Statements
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
THIRD QUARTER ENDED YEAR TO DATE FULL YEAR
2026 2025 2026 2025 2025
Revenues
Rental income $ 277,601 $ 287,399 $ 815,726 $ 863,326 $ 1,138,056
Interest income 1,125 3,480 8,103 10,660 14,275
Other operating 7,915 6,886 23,650 20,257 28,215
Total revenues 286,641 297,765 847,479 894,243 1,180,546
Expenses
Property operating 102,446 107,657 301,485 321,751 424,855
General and administrative 12,435 21,771 44,139 58,782 72,569
Normalizing items 1 (991 ) (12,046 ) (10,453 ) (22,849 ) (26,318 )
Normalized general and administrative 11,444 9,725 33,686 35,933 46,251
Transaction costs 1,693 125 4,102 1,729 2,029
Depreciation and amortization 128,101 143,640 385,152 453,150 588,186
Total expenses 244,675 273,193 734,878 835,412 1,087,639
Other income (expense)
Interest expense before merger-related fair value (35,742 ) (41,927 ) (103,634 ) (129,059 ) (166,396 )
Merger-related fair value adjustment (9,107 ) (10,715 ) (30,251 ) (31,741 ) (42,593 )
Interest expense (44,849 ) (52,642 ) (133,885 ) (160,800 ) (208,989 )
Gain on sales of real estate properties and other assets 2,476 76,771 16,966 99,678 235,389
Loss on extinguishment of debt — (286 ) (1,718 ) (286 ) (451 )
Impairment of real estate assets and credit loss recoveries (reserves) (16,152 ) (104,362 ) (57,909 ) (258,791 ) (364,598 )
Equity income (loss) from unconsolidated joint ventures 816 287 4,241 446 (188 )
Interest and other income (expense), net (108 ) (2,884 ) (82 ) (3,154 ) (3,555 )
Total other income (expense) (57,817 ) (83,116 ) (172,387 ) (322,907 ) (342,392 )
Net loss $ (15,851 ) $ (58,544 ) $ (59,786 ) $ (264,076 ) $ (249,485 )
Net loss attributable to non-controlling interests 96 806 461 3,614 3,414
Net loss attributable to common stockholders $ (15,755 ) $ (57,738 ) $ (59,325 ) $ (260,462 ) $ (246,071 )
Basic earnings per common share $ (0.05 ) $ (0.17 ) $ (0.18 ) $ (0.75 ) $ (0.71 )
Diluted earnings per common share $ (0.05 ) $ (0.17 ) $ (0.18 ) $ (0.75 ) $ (0.71 )
Weighted average common shares outstanding - basic 340,616 349,964 343,427 349,712 349,798
Weighted average common shares outstanding - diluted2 340,616 349,964 343,427 349,712 349,798
  1. Normalizing items primarily include restructuring, severance-related costs and other.
  2. Potential common shares are not included in the computation of diluted earnings per share when a loss exists (or when dividends paid are greater than income), as the effect would be an antidilutive per share amount. As a result, the outstanding limited partnership units in the Company's operating partnership ("OP"), totaling 4,229,701 units were not included.
FFO, Normalized FFO and FAD
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
THIRD QUARTER ENDED YEAR TO DATE FULL YEAR
2026 2025 2026 2025 2025
Net loss attributable to common stockholders $ (15,755 ) $ (57,738 ) $ (59,325 ) $ (260,462 ) $ (246,071 )
Net loss attributable to common stockholders per diluted share $ (0.05 ) $ (0.17 ) $ (0.18 ) $ (0.75 ) $ (0.71 )
Gain on sales of real estate assets (2,476 ) (76,771 ) (16,966 ) (99,678 ) (235,389 )
Impairments of real estate assets 16,152 104,362 58,909 255,384 361,090
Real estate depreciation and amortization 127,020 143,187 381,896 451,411 586,146
Non-controlling loss from operating partnership units (194 ) (806 ) (741 ) (3,698 ) (3,497 )
Unconsolidated JV depreciation, amortization, gain and impairment 6,919 6,688 17,733 20,111 27,769
NAREIT FFO $ 131,666 $ 118,922 $ 381,506 $ 363,068 $ 490,048
NAREIT FFO per common share - diluted $ 0.38 $ 0.34 $ 1.10 $ 1.02 $ 1.38
Transaction costs 1,693 125 4,102 1,729 2,029
Debt financing costs 25 3,493 1,917 3,493 5,107
Restructuring and severance-related charges 2,031 12,046 12,615 22,849 26,318
Merger-related fair value adjustment 9,107 10,715 30,251 31,741 42,593
Other 1,406 39 3,622 3,918 2,851
Normalized FFO $ 145,928 $ 145,340 $ 434,013 $ 426,798 $ 568,946
Normalized FFO per common share - diluted $ 0.42 $ 0.41 $ 1.25 $ 1.20 $ 1.61
Non-real estate depreciation and amortization 749 1,139 2,200 3,592 6,114
Non-cash interest amortization, net 1,495 1,384 4,242 3,731 5,126
Straight-line amortization, net (12,332 ) (6,924 ) (36,338 ) (22,837 ) (29,392 )
Stock-based compensation 4,561 3,386 12,909 10,301 13,609
Unconsolidated JV non-cash items (169 ) (463 ) (423 ) (1,073 ) (1,420 )
Other — 146 — 370 952
Maintenance capital and LCs (30,058 ) (27,155 ) (84,211 ) (86,455 ) (115,633 )
FAD $ 110,174 $ 116,853 $ 332,392 $ 334,427 $ 448,302
Quarterly dividends and OP distributions $ 83,347 $ 85,536 $ 251,515 $ 305,862 $ 391,368
FFO wtd avg common shares outstanding - diluted 1 345,568 354,690 348,292 354,294 354,454
  1. The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 722,102 for the three months ended September 30, 2026. Also includes the diluted impact of 4,229,701 OP units outstanding.
Non-GAAP Measures

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, and funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, and share-based compensation expense; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income plus interest from financing receivables less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, financing receivable amortization, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction through the application of additional resources, including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

Any recently acquired property will be included in the same store pool once the Company has owned the property for five full quarters. Newly developed or redeveloped properties will be included in the same store pool five full quarters after substantial completion.

Primary Logo

Source: Healthcare Realty Trust Incorporated

Healthcare Realty Trust Incorporated
3310 West End Avenue, Suite 700
Nashville, Tennessee 37203
P: 615.269.8175 F: 615.269.8461
© 2023 Healthcare Realty Trust. All rights reserved.

Company Release - 10/12/2026

NASHVILLE, Tenn., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE: HR) today released its eighth annual Corporate Responsibility Report, highlighting the Company’s 2025 environmental, social, and governance (ESG) initiatives and accomplishments. The report outlines the Company’s progress toward its stated key performance indicators, environmental performance, and disclosures that align with the Task Force on Climate-Related Financial Disclosures (TCFD) and the Sustainability Accounting Standards Board (SASB).

Healthcare Realty’s 2025 achievements include:

  • Awarded GRESB’s Green Star rating, earning a score of 75 on its 2025 GRESB assessment

  • For the sixth consecutive year, received GRESB’s Public Disclosure rating of “A” for transparency in public reporting on sustainability practices

  • Decreased Scope 1 and Scope 2 emissions by 8.6%, energy consumption by 1.3%, and water consumption by 2.3% over the 2022 baseline

  • Completed two LEED-certified developments, a 106,000 square foot building in Nashville, TN, certified in April 2025, and a 101,000 square foot building in Fort Worth, TX, certified in May 2026.

  • Achieved our green building certification goal, reaching 12% of our portfolio, totaling 5.7 million square feet

“2025 was a transformational year for Healthcare Realty, and the progress we’ve made since launching our Strategic Plan demonstrates the impact of sharper portfolio management, stronger operations, and greater financial discipline,” said Peter Scott, President and CEO. “At the same time, we continued to advance our commitment to responsible stewardship by reducing our environmental impact, investing in our people and properties, and strengthening the partnerships that help health systems deliver high-quality outpatient care.”

Healthcare Realty’s 2026 Corporate Responsibility Report includes data for properties over which the Company held operational control and authority to exercise investment decisions during the reporting year. The report and additional information about the Company’s corporate responsibility performance and policies can be found on its website at www.healthcarerealty.com/sustainability

Company Release - 10/05/2026

NASHVILLE, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that on Thursday, October 29, 2026, after the market closes, it is scheduled to report results for the third quarter of 2026.

On October 30, 2026, at 9:00 a.m. Eastern Time, Healthcare Realty Trust is scheduled to hold a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.

Simultaneously, a webcast of the conference call will be available to interested parties at www.investors.healthcarerealty.com . A webcast replay will be available following the call at the same address.

Conference Call Details

Domestic Dial-In Number: 1.833.461.5787

International Dial-In Number: 1.585.542.9983

Meeting ID Number: 162 480 934

About Healthcare Realty

Healthcare Realty Trust Incorporated (NYSE: HR) is the largest public, pure-play owner, operator and developer of medical outpatient buildings in the United States.

Additional information regarding the Company can be found at www.healthcarerealty.com .

Investor Relations
[email protected]

P: 615.269.8175

Primary Logo

Source: Healthcare Realty Trust Incorporated

Healthcare Realty Trust Incorporated
3310 West End Avenue, Suite 700
Nashville, Tennessee 37203
P: 615.269.8175 F: 615.269.8461
© 2023 Healthcare Realty Trust. All rights reserved.

Prompts

Healthcare Realty Trust Incorporated (ticker HR), listed in United States.

Company History

Date Change Detail
Jun 21, 2022 Renamed Healthcare Trust of America Holdings, LP → HEALTHCARE REALTY TRUST INC
Aug 24, 2009 Renamed Grubb & Ellis Healthcare REIT, Inc. → HEALTHCARE TRUST OF AMERICA, INC.
Dec 11, 2007 Renamed NNN Healthcare/Office REIT, Inc. → Grubb & Ellis Healthcare REIT, Inc.
— Predecessor Predecessor Healthcare Realty Trust Inc (CIK 899749) filed under its own registration; its figures are on its own company page, not shown here.

ETFs Holding Healthcare Realty Trust Incorporated

ETF Weight in ETF Shares Market value As of
ADPV 4.34% 368,761 $ 7.748M Jul 31, 2026
CVSM 2.23% 100,232 $ 2.106M Jul 31, 2026
SPCT 2.01% 64,475 $ 1.355M Jul 31, 2026
VUS 1.14% 9,700 $ 203.797K Jul 31, 2026
CSRE 1.11% 242,880 $ 4.899M Jun 30, 2026
FTKI 0.76% 9,941 $ 192.06K Nov 16, 2026
SMDX 0.74% 48,437 $ 935.803K Nov 17, 2026
IYRI 0.51% 86,106 $ 1.528M Sep 30, 2026
DFAR 0.48% 2,165,562 $ 41.492M Nov 12, 2026
SIXL 0.41% 44,297 $ 848.731K Nov 12, 2026
TMSL 0.40% 539,204 $ 10.876M Jun 30, 2026
AVRE 0.33% 150,300 $ 2.904M Nov 16, 2026
HSMV 0.32% 910 $ 17.581K Nov 16, 2026
DFGR 0.32% 666,600 $ 12.772M Nov 12, 2026
AFMC 0.26% 36,018 $ 695.868K Nov 16, 2026
MKTN short -0.24% -12,700 $ -256.159K Jun 30, 2026
FLDZ 0.22% 441 $ 8,894.97 Jun 30, 2026
SYZ 0.16% 5,467 $ 110.269K Jun 30, 2026
BALI 0.15% 117,638 $ 2.273M Nov 16, 2026
CAPE 0.13% 15,495 $ 312.534K Jun 30, 2026
JMEE 0.13% 196,744 $ 3.789M Nov 17, 2026
INRO 0.01% 1,840 $ 35.549K Nov 16, 2026